Research & Development: Page 49
-
PharmaVoice Team/PharmaVoice
Innovator's Corner
A New Targeted Cancer Treatment Dr. Joshua Allen, VP for Research and Development at Oncoceutics, talks about his company’s approach to target cancer. Targeted therapies are the focus of many cancer drug development programs. They are a cornerstone of precision medicine, which uses information a...
By Dr Joshua Allen • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Protocol Amendments Come at a High Cost Trending now: New analysis provides insight into the impact of clinical trial amendments and how to anticipate and manage them. Research sponsors implement at least one substantial global amendment for almost 60% of all clinical trial protocols, substantia...
By PharmaVoice Team • March 1, 2016 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Preparing for an Outcomes-based Sales Model
According to a recent report by Accenture, three factors — reimbursement models, changing buyer profiles, and digital capabilities — are changing the pharmaceutical and healthcare industries and directly impacting the traditional pharmaceutical sales rep model. However, these factors also represe...
By Robin Robinson • March 1, 2016 -
PharmaVoice Team/PharmaVoice
The Microbiome: A New Research Tool
Our bodies are home to trillions of microbes, including bacteria, fungi, and viruses. These microbes are essential; they help digest food, produce certain vitamins, and regulate the immune system. Until recently, little was known about these microbes, but advances in DNA sequencing are making it ...
By Denise Myshko • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Biopharma Sales Operations Stabilizing Trending now: Growth in sales operations spending driven by changing biopharma challenges and priorities. The biopharmaceutical sales operations rollercoaster ride appears to have leveled off, according to TGaS Advisors. A recent TGaS Commercial Operations L...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The Pennsylvania BIO 2016 Annual Dinner and Awards Celebration is the premier event of the season for the life-sciences industry in Pennsylvania. On March 10th, more than 1,000 attendees will convene for this can’t-miss event Thursday, March 10, 2016, at the PA Convention Cente...
By PharmaVoice Team • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Outsourcing: Strategic Partnerships
After years of paying lip service to the need for truly strategic partnerships between sponsors and CROs as a way to increase efficiencies, improve timelines to market, and reduce costs, the time may be right for both parties. According to Nice Insights’ most recent survey 2016 CRO Buying Trends,...
By Taren Grom • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
Countdown to Launch: Strategies For Efficiency, Acceleration and Performance
As new drug launches proliferate in the increasingly complex specialty therapeutic space, biopharma is finding that success is often pre-determined by actions that take place very early in the development and commercialization cycle. In fact, the earlier companies start thinking through their lau...
By Dean Giovanniello • Feb. 1, 2016 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large Helping Kids with Asthma Medikidz and Meda Pharmaceuticals have launched Explain Asthma, a comic book series launched in conjunction with the American College of Asthma, Allergy, and Immunology (ACAAI). The series is designed to help families gain an accurate understanding of as...
By PharmaVoice Team • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Modifying the Immune System for Those with Food Allergies DBV Technologies’ CEO and Co-founder Pierre-Henri Benhamou talks about his company’s development of a patch for peanut and other food allergies. The prevalence of food allergies appears to be on the rise. While there is no cure for food al...
By Pierre-Henri Benhamou • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
Last Word
Filling Unmet Needs for Patients David Meek, Executive VP and President, Oncology, Baxalta, talks about how pharmaceutical companies can bridge the research gap in areas of high unmet need. PV: What do you think is needed to translate scientific advances into real benefits for patients? Meek: Col...
By David Meek • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Brain: The Decade Ahead
The three-pound organ — made up of more than 100 billion nerves — that serves as the center of the nervous system is one of the most complex parts of the human body. Only recently have researchers and scientists begun to understand the brain and what can go wrong. This special forum kicks off a y...
By Denise Myshko and Robin Robinson • Jan. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
CROs’ Use of eTMF Apps Increases: Veeva Survey Trending Now: A majority of CROs cite speeding study start-up as top driver for eTMF technology adoption. A significant number of contract research organizations (CROs) are increasingly using electronic trial master file (eTMF) applications, accor...
By PharmaVoice Team • Nov. 15, 2015 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
TGaS Insights Launches Report Service for Pharmaceutical Commercial Leaders Trending Now: New service provides an “outside-in" perspective on what’s happening beyond the four walls of life-sciences companies. TGaS Insights, a division of TGaS Advisors, has launched TGaS Insights Reports, a new ...
By PharmaVoice Team • Nov. 15, 2015 -
PharmaVoice Team/PharmaVoice
2016 The Year Ahead
For this special issue — the Year in Preview: 2016 — we identified 10 major trends that are expected to continue to disrupt the industry in new and different ways. There were a multitude of industry drivers from a multitude of industry sources to consider. We identified these 10 trends — that spa...
By Taren Grom • Nov. 15, 2015 -
PharmaVoice Team/PharmaVoice
The Brain in the Decade Ahead
In 2013, President Obama launched the Brain Research through Advancing Innovative Neurotechnologies, or BRAIN Initiative, as a large-scale effort to equip researchers with fundamental insights necessary for treating a wide variety of brain disorders such as Alzheimer’s, schizophrenia, autism, epi...
By Taren Grom • Nov. 15, 2015 -
PharmaVoice Team/PharmaVoice
Smart Medtech: The Smart Healthcare Environment
Progress in technology, coupled with medical and scientific advances, is expected to significantly change the healthcare environment. Technology companies, healthcare companies, medical device companies, and others are capitalizing on emerging technologies to provide novel healthcare solutions us...
By Denise Myshko • Nov. 15, 2015 -
PharmaVoice Team/PharmaVoice
New Entrants: The Healthcare Disrupters
The traditional boundaries between industries and areas of specialization continue to blur. Some of this is being driven by the rise of the Internet of Things and the Internet of Medical Things, as dozens of companies such as Apple, DuPont, General Electric, Google, IBM, and Samsung are shaking u...
By Denise Myshko • Nov. 15, 2015 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Crowdsourcing is a social phenomenon that is providing a platform for everything from funding small businesses to compiling data for research and development of pharmaceuticals and medical devices. Imagine the possibilities of being able to solve and predict disease challenges through the collect...
By Taren Grom • Oct. 1, 2015 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Payer Pressures, Market Access Weigh Upon Life-Sciences Strategy Trending Now: Biotech, pharma, medical device managers find payer pressures and utilization limits sway commercialization approach. Drug makers and medical device companies are finding their biggest commercial challenges coming fro...
By PharmaVoice Team • Oct. 1, 2015 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
FusionOps Launches Supply Chain Analytics Trending Now: Cloud solution provides supply chain visibility to help pharma companies drive growth and reduce cost. FusionOps has launched FusionOps Pharma, a new analytics suite designed specifically for the pharmaceutical industry. The new cloud solut...
By PharmaVoice Team • Oct. 1, 2015 -
PharmaVoice Team/PharmaVoice
R&D Moves Slowly Toward Open Source
Open access and crowdsourcing scientific information to accelerate research and development requires a new way of thinking about how clinical research is conducted and breaking down competitive barriers for the greater good. Crowdsourcing is the process of getting work or funding, usually online,...
By Denise Myshko • Oct. 1, 2015 -
PharmaVoice Team/PharmaVoice
Beyond Medical Marijuana
The broad reaching war on drugs that began more than 40 years ago had an unintended consequence: research on the therapeutic value of controlled substances such marijuana, psychedelics, narcotics, and stimulants stalled. Controlled substances were difficult for researchers to get and research was...
By Denise Myshko • Oct. 1, 2015 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A New Way to Address Drug-Resistant Infections Magnus Precht, CEO and Co-founder of SinSa Labs, talks about his company’s work to develop a new class of antibiotics engineered to avert antibiotic resistance. Experts say in the future, the crisis in antibiotic resistance will be in E. coli, Klebsi...
By Magnus Precht of SinSa Labs • Sept. 1, 2015 -
PharmaVoice Team/PharmaVoice
The Network
Social Media Plays Crucial Role In Patient Recruitment For Diabetes Clinical Trial Trending Now: Social media improves clinical study operations. Dr. Frank Waldron-Lynch from the University of Cambridge implemented a research study to analyze the performance of three recruitment sources and the e...
By PharmaVoice Team • Sept. 1, 2015
Previous
